Gt Biopharma, INC. (GTBP) SEC Filings — 2025
20 SEC filings for Gt Biopharma, INC. (GTBP) in 2025.
Filings
- GT Biopharma Faces Delisting Concerns — 8-K · Nov 26, 2025
- GT Biopharma Narrows Losses, Equity Turns Positive Amid Cash Burn — 10-Q · Nov 14, 2025
- GT Biopharma Registers 14.6M Shares for Resale, Cites Going Concern Doubt — S-1 · Oct 24, 2025
- GT Biopharma Files 8-K on Security Holder Rights — 8-K · Sep 26, 2025
- GT Biopharma Files 8-K on Security Holder Rights — 8-K · Sep 23, 2025
- GT Biopharma Reports Director Changes and Officer Compensation — 8-K · Aug 29, 2025
- GT Biopharma Narrows Losses, Raises Capital Amid Going Concern Doubts — 10-Q · Aug 14, 2025
- GT Biopharma Files 8-K on Security Holder Vote — 8-K · Jul 24, 2025
- GT Biopharma Amends S-1, Signals Capital Raise Intent — S-1/A · Jun 27, 2025
- GT Biopharma Files 8-K on Agreements and Personnel Changes — 8-K · Jun 11, 2025
- GT Biopharma Reports Material Definitive Agreement & Equity Sales — 8-K · May 27, 2025
- GT Biopharma Files Q1 2025 10-Q — 10-Q · May 15, 2025
- GT Biopharma Files 8-K on Material Agreements & Equity Sales — 8-K · May 13, 2025
- GT Biopharma Reports Director/Officer Changes — 8-K · May 5, 2025
- GT Biopharma Files 2024 Annual Report Amendment — 10-K/A · Apr 14, 2025
- GT Biopharma Reports Unregistered Equity Sales — 8-K · Apr 4, 2025
- GT Biopharma Files 8-K on Agreements and Equity Sales — 8-K · Feb 26, 2025
- GT Biopharma Files 2024 Annual Report — 10-K · Feb 21, 2025
- GT Biopharma Files S-1/A Amendment — S-1/A · Feb 7, 2025
- Gt Biopharma, INC. 8-K Filing — 8-K · Jan 27, 2025